Cardiovascular System Involvement in Cystic Fibrosis

• Published in: Curēus (Palo Alto, CA) Vol. 13; no. 7; p. e16723
• Main Authors: Shah, Prutha H, Lee, Jun Hee, Salvi, Dhairya J, Rabbani, Rizwan, Gavini, Divya R, Hamid, Pousette
• Format: Journal Article
• Language: English
• Published: United States Cureus 29-07-2021
• Subjects: Cardiology; Genetics; Internal Medicine; cor pulmonale; cardiovascular system; cystic fibrosis; cftr; myocardial fibrosis
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.16723

Cystic fibrosis (CF) is an autosomal recessive disease primarily affecting the respiratory system and gastrointestinal system. The life expectancy of patients with CF has significantly improved due to medical advancement and the effective use of screening techniques. However, new challenges have emerged. Particularly those involving cardiovascular pathology. This study aims to provide a better understanding of the different mechanisms that cause cardiovascular complications in patients with CF, which would help find an efficient treatment that not only prolongs survival but also improves their quality of life. This study extensively reviews different theories such as right ventricular hypertrophy due to lung pathology, ventricular interdependence, the association of nutritional deficiencies and severe cystic fibrosis transmembrane conductance regulator (CFTR) genotypes with myocardial fibrosis, effects of hypoxia, recurrent infections, and systemic inflammation of the heart and blood vessels that explain the direct or indirect involvement of the cardiovascular system in CF. For this review, 258 articles were retrieved from PubMed and Google Scholar. Out of which, a total of 12 high-quality articles were selected using appropriate quality assessment tools and preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. The result of this study suggests that early detection of cardiovascular dysfunction can improve the survival rate of the patient. Furthermore, this study could aid future researchers in the exploration of various best screening modality techniques for the early detection of cardiovascular dysfunction.